• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

3-羟基嘧啶-2,4-二酮-5-N-苄基羧酰胺可有效抑制HIV-1整合酶和核糖核酸酶H。

3-Hydroxypyrimidine-2,4-dione-5-N-benzylcarboxamides Potently Inhibit HIV-1 Integrase and RNase H.

作者信息

Wu Bulan, Tang Jing, Wilson Daniel J, Huber Andrew D, Casey Mary C, Ji Juan, Kankanala Jayakanth, Xie Jiashu, Sarafianos Stefan G, Wang Zhengqiang

机构信息

Center for Drug Design, Academic Health Center, University of Minnesota , Minneapolis, Minnesota 55455, United States.

Department of Molecular Microbiology and Immunology and Department of Biochemistry, Christopher S. Bond Life Sciences Center, University of Missouri , Columbia, Missouri 65211, United States.

出版信息

J Med Chem. 2016 Jul 14;59(13):6136-48. doi: 10.1021/acs.jmedchem.6b00040. Epub 2016 Jun 17.

DOI:10.1021/acs.jmedchem.6b00040
PMID:27283261
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4945466/
Abstract

Resistance selection by human immunodeficiency virus (HIV) toward known drug regimens necessitates the discovery of structurally novel antivirals with a distinct resistance profile. On the basis of our previously reported 3-hydroxypyrimidine-2,4-dione (HPD) core, we have designed and synthesized a new integrase strand transfer (INST) inhibitor type featuring a 5-N-benzylcarboxamide moiety. Significantly, the 6-alkylamino variant of this new chemotype consistently conferred low nanomolar inhibitory activity against HIV-1. Extended antiviral testing against a few raltegravir-resistant HIV-1 clones revealed a resistance profile similar to that of the second generation INST inhibitor (INSTI) dolutegravir. Although biochemical testing and molecular modeling also strongly corroborate the inhibition of INST as the antiviral mechanism of action, selected antiviral analogues also potently inhibited reverse transcriptase (RT) associated RNase H, implying potential dual target inhibition. In vitro ADME assays demonstrated that this novel chemotype possesses largely favorable physicochemical properties suitable for further development.

摘要

人类免疫缺陷病毒(HIV)对已知药物方案产生耐药性,这就需要发现具有独特耐药谱的结构新颖的抗病毒药物。基于我们之前报道的3-羟基嘧啶-2,4-二酮(HPD)核心结构,我们设计并合成了一种新型整合酶链转移(INST)抑制剂,其具有5-N-苄基甲酰胺部分。值得注意的是,这种新化学类型的6-烷基氨基变体对HIV-1始终具有低纳摩尔抑制活性。对一些对拉替拉韦耐药的HIV-1克隆进行的扩展抗病毒测试显示,其耐药谱与第二代INST抑制剂度鲁特韦相似。尽管生化测试和分子建模也有力地证实了对整合酶的抑制是抗病毒作用机制,但所选的抗病毒类似物也能有效抑制逆转录酶(RT)相关的核糖核酸酶H,这意味着可能具有双重靶点抑制作用。体外药物代谢及药物动力学(ADME)分析表明,这种新型化学类型具有很大程度上有利的物理化学性质,适合进一步开发。

相似文献

1
3-Hydroxypyrimidine-2,4-dione-5-N-benzylcarboxamides Potently Inhibit HIV-1 Integrase and RNase H.3-羟基嘧啶-2,4-二酮-5-N-苄基羧酰胺可有效抑制HIV-1整合酶和核糖核酸酶H。
J Med Chem. 2016 Jul 14;59(13):6136-48. doi: 10.1021/acs.jmedchem.6b00040. Epub 2016 Jun 17.
2
6-Arylthio-3-hydroxypyrimidine-2,4-diones potently inhibited HIV reverse transcriptase-associated RNase H with antiviral activity.6-芳基硫代-3-羟基嘧啶-2,4-二酮可强效抑制具有抗病毒活性的 HIV 逆转录酶相关核糖核酸酶 H。
Eur J Med Chem. 2018 Aug 5;156:652-665. doi: 10.1016/j.ejmech.2018.07.039. Epub 2018 Jul 17.
3
6-Biphenylmethyl-3-hydroxypyrimidine-2,4-diones potently and selectively inhibited HIV reverse transcriptase-associated RNase H.6-联苯甲基-3-羟基嘧啶-2,4-二酮能强烈且选择性地抑制 HIV 逆转录酶相关的核糖核酸酶 H。
Eur J Med Chem. 2018 Aug 5;156:680-691. doi: 10.1016/j.ejmech.2018.07.035. Epub 2018 Jul 17.
4
6-Cyclohexylmethyl-3-hydroxypyrimidine-2,4-dione as an inhibitor scaffold of HIV reverase transcriptase: Impacts of the 3-OH on inhibiting RNase H and polymerase.6-环己基甲基-3-羟基嘧啶-2,4-二酮作为HIV逆转录酶的抑制剂支架:3-羟基对抑制核糖核酸酶H和聚合酶的影响。
Eur J Med Chem. 2017 Mar 10;128:168-179. doi: 10.1016/j.ejmech.2017.01.041. Epub 2017 Jan 30.
5
Past and future. Current drugs targeting HIV-1 integrase and reverse transcriptase-associated ribonuclease H activity: single and dual active site inhibitors.过去与未来。目前针对HIV-1整合酶和逆转录酶相关核糖核酸酶H活性的药物:单活性位点和双活性位点抑制剂。
Antivir Chem Chemother. 2014 Jan 29;23(4):129-44. doi: 10.3851/IMP2690.
6
New insights into the interaction between pyrrolyl diketoacids and HIV-1 integrase active site and comparison with RNase H.吡咯基二酮酸与HIV-1整合酶活性位点相互作用的新见解及与核糖核酸酶H的比较。
Antiviral Res. 2016 Oct;134:236-243. doi: 10.1016/j.antiviral.2016.09.008. Epub 2016 Sep 20.
7
The HIV-1 integrase E157Q polymorphism per se does not alter susceptibility to raltegravir and dolutegravir in vitro.HIV-1 整合酶 E157Q 多态性本身不会改变体外对拉替拉韦和多替拉韦的敏感性。
AIDS. 2017 Oct 23;31(16):2307-2309. doi: 10.1097/QAD.0000000000001616.
8
Combination of two pathways involved in raltegravir resistance confers dolutegravir resistance.参与拉替拉韦耐药的两条途径联合导致多替拉韦耐药。
J Antimicrob Chemother. 2015 Oct;70(10):2870-80. doi: 10.1093/jac/dkv197. Epub 2015 Jul 23.
9
Design and synthesis of N-methylpyrimidone derivatives as HIV-1 integrase inhibitors.作为HIV-1整合酶抑制剂的N-甲基嘧啶酮衍生物的设计与合成
Bioorg Med Chem. 2015 Feb 15;23(4):735-41. doi: 10.1016/j.bmc.2014.12.059. Epub 2015 Jan 3.
10
Natural polymorphism S119R of HIV-1 integrase enhances primary INSTI resistance.HIV-1整合酶的自然多态性S119R增强了对第一代整合酶链转移抑制剂的耐药性。
Antiviral Res. 2015 Jul;119:84-8. doi: 10.1016/j.antiviral.2015.04.014. Epub 2015 May 5.

引用本文的文献

1
Inhibiting HCMV pUL89-C Endonuclease with Metal-Binding Compounds.用金属结合化合物抑制 HCMV pUL89-C 内切酶。
J Med Chem. 2023 Oct 26;66(20):13874-13887. doi: 10.1021/acs.jmedchem.3c01280. Epub 2023 Oct 12.
2
Targeting Ribonucleases with Small Molecules and Bifunctional Molecules.靶向核糖核酸酶的小分子和双功能分子。
ACS Chem Biol. 2023 Oct 20;18(10):2101-2113. doi: 10.1021/acschembio.3c00191. Epub 2023 Jun 29.
3
Repurposing N-hydroxy thienopyrimidine-2,4-diones (HtPD) as inhibitors of human cytomegalovirus pUL89 endonuclease: Synthesis and biological characterization.

本文引用的文献

1
Design, synthesis, biochemical, and antiviral evaluations of C6 benzyl and C6 biarylmethyl substituted 2-hydroxylisoquinoline-1,3-diones: dual inhibition against HIV reverse transcriptase-associated RNase H and polymerase with antiviral activities.C6苄基和C6联芳基甲基取代的2-羟基异喹啉-1,3-二酮的设计、合成、生化及抗病毒评估:对HIV逆转录酶相关核糖核酸酶H和聚合酶的双重抑制及抗病毒活性
J Med Chem. 2015 Jan 22;58(2):651-64. doi: 10.1021/jm501132s. Epub 2014 Dec 30.
2
Immunologic strategies for HIV-1 remission and eradication.HIV-1 缓解和清除的免疫策略。
Science. 2014 Jul 11;345(6193):169-74. doi: 10.1126/science.1255512.
3
将 N-羟基噻吩并嘧啶-2,4-二酮(HtPD)重新用作人巨细胞病毒 pUL89 内切酶抑制剂:合成与生物学特性。
Bioorg Chem. 2022 Dec;129:106198. doi: 10.1016/j.bioorg.2022.106198. Epub 2022 Oct 12.
4
8-Hydroxy-1,6-naphthyridine-7-carboxamides as Inhibitors of Human Cytomegalovirus pUL89 Endonuclease.8-羟基-1,6-萘啶-7-甲酰胺作为人巨细胞病毒 pUL89 内切酶抑制剂。
ChemMedChem. 2022 Sep 5;17(17):e202200334. doi: 10.1002/cmdc.202200334. Epub 2022 Aug 10.
5
4,5-Dihydroxypyrimidine Methyl Carboxylates, Carboxylic Acids, and Carboxamides as Inhibitors of Human Cytomegalovirus pUL89 Endonuclease.4,5-二羟嘧啶甲酯、羧酸和羧酰胺作为人巨细胞病毒 pUL89 内切酶抑制剂。
J Med Chem. 2022 Apr 14;65(7):5830-5849. doi: 10.1021/acs.jmedchem.2c00203. Epub 2022 Apr 4.
6
Metal binding 6-arylthio-3-hydroxypyrimidine-2,4-diones inhibited human cytomegalovirus by targeting the pUL89 endonuclease of the terminase complex.金属结合 6-芳基硫代-3-羟基嘧啶-2,4-二酮通过靶向末端酶复合物的 pUL89 内切酶抑制人巨细胞病毒。
Eur J Med Chem. 2021 Oct 15;222:113640. doi: 10.1016/j.ejmech.2021.113640. Epub 2021 Jun 12.
7
Structural Biology of HIV Integrase Strand Transfer Inhibitors.HIV 整合酶链转移抑制剂的结构生物学。
Trends Pharmacol Sci. 2020 Sep;41(9):611-626. doi: 10.1016/j.tips.2020.06.003. Epub 2020 Jul 3.
8
Cutting into the Substrate Dominance: Pharmacophore and Structure-Based Approaches toward Inhibiting Human Immunodeficiency Virus Reverse Transcriptase-Associated Ribonuclease H.切入基质优势:基于药效团和结构的方法抑制人类免疫缺陷病毒逆转录酶相关核糖核酸酶 H。
Acc Chem Res. 2020 Jan 21;53(1):218-230. doi: 10.1021/acs.accounts.9b00450. Epub 2019 Dec 27.
9
Determinants of Active-Site Inhibitor Interaction with HIV-1 RNase H.HIV-1核糖核酸酶H活性位点抑制剂相互作用的决定因素
ACS Infect Dis. 2019 Nov 8;5(11):1963-1974. doi: 10.1021/acsinfecdis.9b00300. Epub 2019 Oct 2.
10
Novel Deazaflavin Analogues Potently Inhibited Tyrosyl DNA Phosphodiesterase 2 (TDP2) and Strongly Sensitized Cancer Cells toward Treatment with Topoisomerase II (TOP2) Poison Etoposide.新型去氮黄素类似物能有效抑制酪氨酰 DNA 磷酸二酯酶 2(TDP2),并能显著增强拓扑异构酶 II(TOP2)毒剂依托泊苷对癌细胞的敏感性。
J Med Chem. 2019 May 9;62(9):4669-4682. doi: 10.1021/acs.jmedchem.9b00274. Epub 2019 Apr 30.
Dolutegravir: clinical efficacy and role in HIV therapy.
多替拉韦:临床疗效及其在 HIV 治疗中的作用。
Ther Adv Chronic Dis. 2014 Jul;5(4):164-77. doi: 10.1177/2040622314530461.
4
An analysis of FDA-approved drugs for infectious disease: HIV/AIDS drugs.美国食品药品监督管理局(FDA)批准的用于治疗传染病的药物分析:抗艾滋病毒/艾滋病药物
Drug Discov Today. 2014 Oct;19(10):1510-3. doi: 10.1016/j.drudis.2014.05.012. Epub 2014 May 28.
5
Clicking 3'-azidothymidine into novel potent inhibitors of human immunodeficiency virus.将 3’-叠氮胸苷点击成新型有效的人类免疫缺陷病毒抑制剂。
J Med Chem. 2013 Nov 14;56(21):8765-80. doi: 10.1021/jm401232v. Epub 2013 Oct 28.
6
Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments.蛋白质和配体准备:参数、方案以及对虚拟筛选富集的影响。
J Comput Aided Mol Des. 2013 Mar;27(3):221-34. doi: 10.1007/s10822-013-9644-8. Epub 2013 Apr 12.
7
HIV reservoirs: pathogenesis and obstacles to viral eradication and cure.HIV 储库:发病机制以及病毒清除和治愈的障碍。
AIDS. 2012 Jun 19;26(10):1261-8. doi: 10.1097/QAD.0b013e328353f3f1.
8
Structural and functional analyses of the second-generation integrase strand transfer inhibitor dolutegravir (S/GSK1349572).第二代整合酶链转移抑制剂多替拉韦(S/GSK1349572)的结构和功能分析。
Mol Pharmacol. 2011 Oct;80(4):565-72. doi: 10.1124/mol.111.073189. Epub 2011 Jun 30.
9
N-3 Hydroxylation of Pyrimidine-2,4-diones Yields Dual Inhibitors of HIV Reverse Transcriptase and Integrase.嘧啶-2,4-二酮的N-3羟基化产生HIV逆转录酶和整合酶的双重抑制剂。
ACS Med Chem Lett. 2011 Jan;2(1):63-67. doi: 10.1021/ml1002162.
10
6-Benzoyl-3-hydroxypyrimidine-2,4-diones as dual inhibitors of HIV reverse transcriptase and integrase.6-苯甲酰基-3-羟基嘧啶-2,4-二酮作为 HIV 逆转录酶和整合酶的双重抑制剂。
Bioorg Med Chem Lett. 2011 Apr 15;21(8):2400-2. doi: 10.1016/j.bmcl.2011.02.069. Epub 2011 Feb 18.